Who Paid My Doc
Wihelma Echevarria Cortes
Pediatric Gastroenterology San Juan, PR Medical Doctor
NPI 1093791923 CMS profile 231293
371 Calle De Diego, Ste 209, San Juan, PR 00923
General payments
$68,053
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$45,857
Through program year 2025, Wihelma Echevarria Cortes of San Juan, PR is reported in the CMS Open Payments database as having received $68,053 across 84 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $45,857 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $13,489 | 7 | |
| 2024 | General | $20,084 | 20 | |
| 2023 | General | $11,718 | 20 | |
| 2022 | General | $7,220 | 11 | |
| 2021 | General | $4,473 | 11 | |
| 2020 | General | $6,020 | 5 | |
| 2019 | General | $5,048 | 10 |
Beside peers
- Wihelma Echevarria Cortes
- Pediatric Gastroenterology median
- Middle half of Pediatric Gastroenterology
- National median
In program year 2025, general payments to Wihelma Echevarria Cortes were reported at $13,489. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.
Show as a table
| Year | Wihelma Echevarria Cortes | Pediatric Gastroenterology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $5,048 | $131 | $41–$311 | $163 |
| 2020 | $6,020 | $79 | $23–$223 | $114 |
| 2021 | $4,473 | $104 | $32–$321 | $132 |
| 2022 | $7,220 | $125 | $37–$331 | $149 |
| 2023 | $11,718 | $169 | $55–$440 | $160 |
| 2024 | $20,084 | $196 | $73–$563 | $164 |
| 2025 | $13,489 | $194 | $81–$540 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
84 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Gastroenterology in Puerto Rico
Leonardo Hormaza
Pediatric Gastroenterology · Santurce, PR
Antonio Del Valle
Pediatric Gastroenterology · San Juan, PR
Rosalyn Diaz
Pediatric Gastroenterology · San Juan, PR
Edwin Torres Reyes
Pediatric Gastroenterology · Arecibo, PR
Ivonne Iglesias Escabi
Pediatric Gastroenterology · Mayaguez, PR
David Fernandez
Pediatric Gastroenterology · San Juan, PR
Related records
Pediatric Gastroenterology in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Gastroenterology
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.